Press Releases

Emmaus Life Sciences Announces Protocol for Study of Pharmaceutical-grade L-glutamine for the Treatment of DiabetesJune 24, 2019

Emmaus to use its pharmaceutical-grade L-glutamine ("PGLG") in a clinical study to determine its efficacy in lowering blood sugar in patients with type II diabetes.

Emmaus Life Sciences' 'Sideline Sickle Cell' Campaign Teams Up with SCTPN for World Sickle Cell Day Event on June 19June 18, 2019

MYnd Analytics and Emmaus Life Sciences Announce Availability of Definitive Joint Proxy Statement/Prospectus Relating to Merger and Spin-off TransactionJune 12, 2019

Emmaus Life Sciences Announces New CFO and EMA OpinionMay 30, 2019

NFL Broadcaster Solomon Wilcots and Emmaus Life Sciences Kick Off “Sideline Sickle Cell” Campaign during National Minority Health MonthApril 15, 2019